NO20010292L - Anvendelse av glukose-opptaks-enhancer for redusering av apoptose - Google Patents
Anvendelse av glukose-opptaks-enhancer for redusering av apoptoseInfo
- Publication number
- NO20010292L NO20010292L NO20010292A NO20010292A NO20010292L NO 20010292 L NO20010292 L NO 20010292L NO 20010292 A NO20010292 A NO 20010292A NO 20010292 A NO20010292 A NO 20010292A NO 20010292 L NO20010292 L NO 20010292L
- Authority
- NO
- Norway
- Prior art keywords
- glucose uptake
- reduce apoptosis
- uptake enhancer
- enhancer
- apoptosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9815872.8A GB9815872D0 (en) | 1998-07-21 | 1998-07-21 | Novel method |
| GBGB9815871.0A GB9815871D0 (en) | 1998-07-21 | 1998-07-21 | Novel compound |
| GBGB9905387.8A GB9905387D0 (en) | 1999-03-09 | 1999-03-09 | Novel method |
| PCT/GB1999/002361 WO2000004890A1 (en) | 1998-07-21 | 1999-07-21 | Use of glucose uptake enhancer for reducing apoptosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010292D0 NO20010292D0 (no) | 2001-01-18 |
| NO20010292L true NO20010292L (no) | 2001-03-08 |
Family
ID=27269407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010292A NO20010292L (no) | 1998-07-21 | 2001-01-18 | Anvendelse av glukose-opptaks-enhancer for redusering av apoptose |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP1098639B1 (no) |
| JP (1) | JP2002521326A (no) |
| KR (1) | KR20010079551A (no) |
| CN (1) | CN1310620A (no) |
| AP (1) | AP2001002036A0 (no) |
| AT (1) | ATE288746T1 (no) |
| AU (1) | AU5053799A (no) |
| BG (1) | BG105250A (no) |
| BR (1) | BR9912117A (no) |
| CA (1) | CA2338211A1 (no) |
| DE (1) | DE69923687T2 (no) |
| DK (1) | DK1098639T3 (no) |
| EA (1) | EA200100165A1 (no) |
| ES (1) | ES2237929T3 (no) |
| HK (1) | HK1037865A1 (no) |
| HU (1) | HUP0103199A3 (no) |
| ID (1) | ID26986A (no) |
| IL (1) | IL140664A0 (no) |
| NO (1) | NO20010292L (no) |
| OA (1) | OA11579A (no) |
| PL (1) | PL345627A1 (no) |
| PT (1) | PT1098639E (no) |
| SI (1) | SI1098639T1 (no) |
| SK (1) | SK1012001A3 (no) |
| TR (1) | TR200100207T2 (no) |
| WO (1) | WO2000004890A1 (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000043007A1 (fr) * | 1999-01-19 | 2000-07-27 | Sankyo Company, Limited | Compositions médicinales à base de troglitazone inhibitrices de l'apoptose |
| WO2001016120A1 (en) | 1999-08-27 | 2001-03-08 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
| JPH05202042A (ja) * | 1992-01-24 | 1993-08-10 | Sankyo Co Ltd | 糖尿病性合併症治療剤 |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| IL120443A (en) * | 1996-03-18 | 2000-07-16 | Sankyo Co | Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis |
| GB9611947D0 (en) * | 1996-06-07 | 1996-08-07 | Glaxo Group Ltd | Medicaments |
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| IL128771A0 (en) * | 1996-09-12 | 2000-01-31 | Sankyo Co | An agent for enhancing the activity of glutathione reductase containing troglitazone and use thereof |
| GB9721692D0 (en) * | 1997-10-13 | 1997-12-10 | Smithkline Beecham Plc | Novel treatment |
| EP1047423B1 (en) * | 1997-11-19 | 2006-05-10 | Takeda Pharmaceutical Company Limited | Novel apoptosis inhibitors |
| AU2781899A (en) * | 1998-02-24 | 1999-09-15 | Trustees Of The University Of Pennsylvania, The | Use of a cardiac purinoceptor to effect cellular glucose uptake |
| WO1999059586A1 (en) * | 1998-05-19 | 1999-11-25 | Regents Of The University Of California | Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis |
| US5968960A (en) * | 1999-01-14 | 1999-10-19 | The Regents Of The University Of California | Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism |
-
1999
- 1999-07-21 ID IDW20010150A patent/ID26986A/id unknown
- 1999-07-21 OA OA1200100010A patent/OA11579A/en unknown
- 1999-07-21 JP JP2000560883A patent/JP2002521326A/ja active Pending
- 1999-07-21 AU AU50537/99A patent/AU5053799A/en not_active Abandoned
- 1999-07-21 EP EP99934914A patent/EP1098639B1/en not_active Expired - Lifetime
- 1999-07-21 AP APAP/P/2001/002036A patent/AP2001002036A0/en unknown
- 1999-07-21 ES ES99934914T patent/ES2237929T3/es not_active Expired - Lifetime
- 1999-07-21 CN CN99808983A patent/CN1310620A/zh active Pending
- 1999-07-21 EP EP04078537A patent/EP1516617A2/en not_active Withdrawn
- 1999-07-21 EA EA200100165A patent/EA200100165A1/ru unknown
- 1999-07-21 PT PT99934914T patent/PT1098639E/pt unknown
- 1999-07-21 SK SK101-2001A patent/SK1012001A3/sk unknown
- 1999-07-21 SI SI9930772T patent/SI1098639T1/xx unknown
- 1999-07-21 KR KR1020017000925A patent/KR20010079551A/ko not_active Application Discontinuation
- 1999-07-21 WO PCT/GB1999/002361 patent/WO2000004890A1/en active IP Right Grant
- 1999-07-21 IL IL14066499A patent/IL140664A0/xx unknown
- 1999-07-21 BR BR9912117-4A patent/BR9912117A/pt not_active IP Right Cessation
- 1999-07-21 HU HU0103199A patent/HUP0103199A3/hu unknown
- 1999-07-21 DE DE69923687T patent/DE69923687T2/de not_active Expired - Fee Related
- 1999-07-21 CA CA002338211A patent/CA2338211A1/en not_active Abandoned
- 1999-07-21 DK DK99934914T patent/DK1098639T3/da active
- 1999-07-21 AT AT99934914T patent/ATE288746T1/de not_active IP Right Cessation
- 1999-07-21 TR TR2001/00207T patent/TR200100207T2/xx unknown
- 1999-07-21 PL PL99345627A patent/PL345627A1/xx not_active Application Discontinuation
-
2001
- 2001-01-18 NO NO20010292A patent/NO20010292L/no unknown
- 2001-02-14 BG BG105250A patent/BG105250A/xx unknown
- 2001-10-31 HK HK01107620A patent/HK1037865A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20010292D0 (no) | 2001-01-18 |
| HUP0103199A3 (en) | 2002-08-28 |
| DK1098639T3 (da) | 2005-06-13 |
| EP1098639A1 (en) | 2001-05-16 |
| AU5053799A (en) | 2000-02-14 |
| OA11579A (en) | 2004-06-01 |
| CN1310620A (zh) | 2001-08-29 |
| DE69923687T2 (de) | 2006-04-06 |
| SK1012001A3 (en) | 2001-08-06 |
| IL140664A0 (en) | 2002-02-10 |
| ES2237929T3 (es) | 2005-08-01 |
| ID26986A (id) | 2001-02-22 |
| EP1516617A2 (en) | 2005-03-23 |
| SI1098639T1 (no) | 2005-08-31 |
| AP2001002036A0 (en) | 2001-03-31 |
| TR200100207T2 (tr) | 2001-05-21 |
| PL345627A1 (en) | 2002-01-02 |
| KR20010079551A (ko) | 2001-08-22 |
| EA200100165A1 (ru) | 2001-08-27 |
| BR9912117A (pt) | 2001-04-10 |
| EP1098639B1 (en) | 2005-02-09 |
| HUP0103199A2 (hu) | 2002-05-29 |
| BG105250A (en) | 2001-11-30 |
| ATE288746T1 (de) | 2005-02-15 |
| DE69923687D1 (de) | 2005-03-17 |
| JP2002521326A (ja) | 2002-07-16 |
| PT1098639E (pt) | 2005-06-30 |
| WO2000004890A1 (en) | 2000-02-03 |
| HK1037865A1 (en) | 2002-02-22 |
| CA2338211A1 (en) | 2000-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI972714A (fi) | Prosessi propeenin terpolymeerien saamiseksi | |
| CY2200151T2 (el) | Χρηση αναστολεων διπεπτιδυλοπεπτιδασης για ρυθμιση του μεταβολισμου της γλυκοζης | |
| HUP0202477A3 (en) | Use of phthalazine derivatives | |
| FI990171A (fi) | Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi | |
| ID28441A (id) | Terapi untuk memperbaiki kesadaran | |
| NO20022624D0 (no) | Heterocyklo-alkylsulfonylderivater som anti- inflammatoriske/smertestillende midler | |
| EP1242071A4 (en) | USE OF PARTHENOLIDE TO INHIBIT CANCER | |
| ID29966A (id) | Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi | |
| IL150187A0 (en) | Novel forms of pravastatin sodium | |
| NO20010292D0 (no) | Anvendelse av glukose-opptaks-enhancer for redusering av apoptose | |
| ID27153A (id) | Senyawa inhibitor spla2 untuk mengobati penyakit | |
| AU7104500A (en) | Use of rafp to inhibit or prevent apoptosis | |
| PT1001962E (pt) | Producao de compostos avermectina | |
| NO20025703L (no) | Fremgangsmåte for fremstilling av vannfritt natriumperklorat | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| NO20010293D0 (no) | Anvendelse av glukose-opptaks-enhancer for redusering av post- ischemi skade av hjertet | |
| PT1175417E (pt) | Compostos substituidos de benzolactamas | |
| ID29104A (id) | Komposisi pemutih kulit untuk pemberian oral | |
| GB2353306B (en) | Improvements to ploughs | |
| ID26666A (id) | Penggunaan agen untuk pencegahan penyakit gusi | |
| DE29816774U1 (de) | Umbaubares Bett | |
| FI981139A0 (fi) | Normobarisen hypoksian käyttö terapeuttisesti | |
| ZA996444B (en) | Composition to enhance skin premeation of topical skin agents. | |
| FI991138A0 (fi) | Normobarisen hypoksian käyttö terapeuttisesti | |
| ITAQ970012A1 (it) | Soluzione per risolvere definitivamente la sudorazione dei piedi |